CD274 and ovarian carcinoma: A preclinical study showed that cisplatin down-regulates the transcription factor c-Myc in human ovarian carcinoma cells by inhibiting miR-145, which increases PD-L1 expression and leads to the apoptosis of CTLs, eventually resulting in cisplatin resistance [116].